AAPL325.84+0.71 (+0.22%) ▲|ABBV259.84-0.15 (-0.06%) ▼|ABT111.32+2.39 (+2.19%) ▲|ACN187.12-0.97 (-0.52%) ▼|ADBE281.61-4.47 (-1.56%) ▼|AMAT438.54-3.31 (-0.75%) ▼|AMD456.87-2.74 (-0.60%) ▼|AMGN438.17+0.05 (+0.01%) ▲|AMT172.15-3.87 (-2.20%) ▼|AMZN254.77-0.15 (-0.06%) ▼|AVGO368.52-1.17 (-0.32%) ▼|AXP329.30+5.11 (+1.58%) ▲|BA209.56+3.90 (+1.90%) ▲|BAC62.38+0.39 (+0.62%) ▲|BKNG199.29+3.60 (+1.84%) ▲|BLK1,109.93-18.18 (-1.61%) ▼|BMY67.25+0.33 (+0.49%) ▲|BNY161.23+0.72 (+0.45%) ▲|BRK-B507.84+5.51 (+1.10%) ▲|C133.51+0.97 (+0.73%) ▲|CAT784.15+4.99 (+0.64%) ▲|CL90.72+1.09 (+1.22%) ▲|CMCSA27.13+0.83 (+3.14%) ▲|COF216.74+5.40 (+2.55%) ▲|COP136.78+0.59 (+0.43%) ▲|COST930.24-9.73 (-1.03%) ▼|CRM254.45-3.66 (-1.42%) ▼|CSCO108.89-0.86 (-0.78%) ▼|CVS98.11+0.51 (+0.52%) ▲|CVX211.96+0.91 (+0.43%) ▲|DE684.61+8.53 (+1.26%) ▲|DHR209.43+2.50 (+1.21%) ▲|DIS108.66+2.44 (+2.30%) ▲|DUK120.61+0.22 (+0.18%) ▲|EMR148.52+0.89 (+0.60%) ▲|FDX321.59-3.29 (-1.01%) ▼|GD364.09-5.33 (-1.44%) ▼|GE330.34-0.75 (-0.23%) ▼|GEV916.36+17.83 (+1.98%) ▲|GILD149.43-0.50 (-0.33%) ▼|GM84.73-0.91 (-1.06%) ▼|GOOG334.51+2.48 (+0.75%) ▲|GOOGL338.17+3.15 (+0.94%) ▲|GS999.83-2.73 (-0.27%) ▼|HD319.65-0.12 (-0.04%) ▼|HON206.60-3.38 (-1.61%) ▼|IBM232.47+1.07 (+0.46%) ▲|INTC90.12+1.15 (+1.29%) ▲|INTU342.80-2.13 (-0.62%) ▼|ISRG373.18+3.93 (+1.07%) ▲|JNJ274.76+3.57 (+1.32%) ▲|JPM354.69-0.26 (-0.07%) ▼|KO88.67+0.67 (+0.76%) ▲|LIN488.49+1.73 (+0.36%) ▲|LLY1,159.72-0.28 (-0.02%) ▼|LMT531.67-12.84 (-2.36%) ▼|LOW201.42+1.37 (+0.68%) ▲|LRCX287.81-2.39 (-0.82%) ▼|MA588.52+7.42 (+1.28%) ▲|MCD261.19+0.08 (+0.03%) ▲|MDLZ62.62+1.01 (+1.63%) ▲|MDT93.35+1.31 (+1.42%) ▲|META593.20+14.66 (+2.53%) ▲|MMM169.72-0.52 (-0.31%) ▼|MO69.77+0.20 (+0.29%) ▲|MRK150.66+0.80 (+0.53%) ▲|MS211.03-0.02 (-0.01%) ▼|MSFT496.11-4.91 (-0.98%) ▼|MU945.58+12.14 (+1.30%) ▲|NEE82.80-0.13 (-0.16%) ▼|NFLX82.17+1.36 (+1.68%) ▲|NKE38.39+0.27 (+0.71%) ▲|NOW137.32-5.58 (-3.90%) ▼|NVDA224.96+7.52 (+3.46%) ▲|ORCL144.73+3.41 (+2.41%) ▲|PEP141.13+1.34 (+0.96%) ▲|PFE28.87+0.32 (+1.12%) ▲|PG147.91+1.70 (+1.16%) ▲|PLTR168.02-11.90 (-6.61%) ▼|PM188.50+1.35 (+0.72%) ▲|QCOM169.10+2.49 (+1.49%) ▲|RTX200.99-4.18 (-2.04%) ▼|SBUX107.27+1.12 (+1.06%) ▲|SCHW108.55+0.27 (+0.24%) ▲|SO88.38+0.29 (+0.33%) ▲|SPG210.22-1.65 (-0.78%) ▼|T26.29+0.29 (+1.12%) ▲|TMO604.75+4.25 (+0.71%) ▲|TMUS187.17+5.01 (+2.75%) ▲|TSLA353.08-3.02 (-0.85%) ▼|TXN255.89+2.55 (+1.01%) ▲|UBER76.82+1.58 (+2.10%) ▲|UNH398.37+2.07 (+0.52%) ▲|UNP290.17-0.45 (-0.15%) ▼|UPS103.49+0.83 (+0.80%) ▲|USB62.34+1.13 (+1.84%) ▲|V377.93+5.26 (+1.41%) ▲|VZ50.63+0.33 (+0.65%) ▲|WFC88.89+1.85 (+2.13%) ▲|WMT106.15+0.23 (+0.22%) ▲|XOM163.26-1.29 (-0.78%) ▼|AAPL325.84+0.71 (+0.22%) ▲|ABBV259.84-0.15 (-0.06%) ▼|ABT111.32+2.39 (+2.19%) ▲|ACN187.12-0.97 (-0.52%) ▼|ADBE281.61-4.47 (-1.56%) ▼|AMAT438.54-3.31 (-0.75%) ▼|AMD456.87-2.74 (-0.60%) ▼|AMGN438.17+0.05 (+0.01%) ▲|AMT172.15-3.87 (-2.20%) ▼|AMZN254.77-0.15 (-0.06%) ▼|AVGO368.52-1.17 (-0.32%) ▼|AXP329.30+5.11 (+1.58%) ▲|BA209.56+3.90 (+1.90%) ▲|BAC62.38+0.39 (+0.62%) ▲|BKNG199.29+3.60 (+1.84%) ▲|BLK1,109.93-18.18 (-1.61%) ▼|BMY67.25+0.33 (+0.49%) ▲|BNY161.23+0.72 (+0.45%) ▲|BRK-B507.84+5.51 (+1.10%) ▲|C133.51+0.97 (+0.73%) ▲|CAT784.15+4.99 (+0.64%) ▲|CL90.72+1.09 (+1.22%) ▲|CMCSA27.13+0.83 (+3.14%) ▲|COF216.74+5.40 (+2.55%) ▲|COP136.78+0.59 (+0.43%) ▲|COST930.24-9.73 (-1.03%) ▼|CRM254.45-3.66 (-1.42%) ▼|CSCO108.89-0.86 (-0.78%) ▼|CVS98.11+0.51 (+0.52%) ▲|CVX211.96+0.91 (+0.43%) ▲|DE684.61+8.53 (+1.26%) ▲|DHR209.43+2.50 (+1.21%) ▲|DIS108.66+2.44 (+2.30%) ▲|DUK120.61+0.22 (+0.18%) ▲|EMR148.52+0.89 (+0.60%) ▲|FDX321.59-3.29 (-1.01%) ▼|GD364.09-5.33 (-1.44%) ▼|GE330.34-0.75 (-0.23%) ▼|GEV916.36+17.83 (+1.98%) ▲|GILD149.43-0.50 (-0.33%) ▼|GM84.73-0.91 (-1.06%) ▼|GOOG334.51+2.48 (+0.75%) ▲|GOOGL338.17+3.15 (+0.94%) ▲|GS999.83-2.73 (-0.27%) ▼|HD319.65-0.12 (-0.04%) ▼|HON206.60-3.38 (-1.61%) ▼|IBM232.47+1.07 (+0.46%) ▲|INTC90.12+1.15 (+1.29%) ▲|INTU342.80-2.13 (-0.62%) ▼|ISRG373.18+3.93 (+1.07%) ▲|JNJ274.76+3.57 (+1.32%) ▲|JPM354.69-0.26 (-0.07%) ▼|KO88.67+0.67 (+0.76%) ▲|LIN488.49+1.73 (+0.36%) ▲|LLY1,159.72-0.28 (-0.02%) ▼|LMT531.67-12.84 (-2.36%) ▼|LOW201.42+1.37 (+0.68%) ▲|LRCX287.81-2.39 (-0.82%) ▼|MA588.52+7.42 (+1.28%) ▲|MCD261.19+0.08 (+0.03%) ▲|MDLZ62.62+1.01 (+1.63%) ▲|MDT93.35+1.31 (+1.42%) ▲|META593.20+14.66 (+2.53%) ▲|MMM169.72-0.52 (-0.31%) ▼|MO69.77+0.20 (+0.29%) ▲|MRK150.66+0.80 (+0.53%) ▲|MS211.03-0.02 (-0.01%) ▼|MSFT496.11-4.91 (-0.98%) ▼|MU945.58+12.14 (+1.30%) ▲|NEE82.80-0.13 (-0.16%) ▼|NFLX82.17+1.36 (+1.68%) ▲|NKE38.39+0.27 (+0.71%) ▲|NOW137.32-5.58 (-3.90%) ▼|NVDA224.96+7.52 (+3.46%) ▲|ORCL144.73+3.41 (+2.41%) ▲|PEP141.13+1.34 (+0.96%) ▲|PFE28.87+0.32 (+1.12%) ▲|PG147.91+1.70 (+1.16%) ▲|PLTR168.02-11.90 (-6.61%) ▼|PM188.50+1.35 (+0.72%) ▲|QCOM169.10+2.49 (+1.49%) ▲|RTX200.99-4.18 (-2.04%) ▼|SBUX107.27+1.12 (+1.06%) ▲|SCHW108.55+0.27 (+0.24%) ▲|SO88.38+0.29 (+0.33%) ▲|SPG210.22-1.65 (-0.78%) ▼|T26.29+0.29 (+1.12%) ▲|TMO604.75+4.25 (+0.71%) ▲|TMUS187.17+5.01 (+2.75%) ▲|TSLA353.08-3.02 (-0.85%) ▼|TXN255.89+2.55 (+1.01%) ▲|UBER76.82+1.58 (+2.10%) ▲|UNH398.37+2.07 (+0.52%) ▲|UNP290.17-0.45 (-0.15%) ▼|UPS103.49+0.83 (+0.80%) ▲|USB62.34+1.13 (+1.84%) ▲|V377.93+5.26 (+1.41%) ▲|VZ50.63+0.33 (+0.65%) ▲|WFC88.89+1.85 (+2.13%) ▲|WMT106.15+0.23 (+0.22%) ▲|XOM163.26-1.29 (-0.78%) ▼|
22.6 C
New York
Wednesday, September 2, 2026

Tag: medicine

newssourceFORcompanyinformationcontent1releasesmarket

Sugar Land Medical Weight Loss Expert, Dr. Adelola Ashaye, Launches Metabolic Wellness & Healthy Weight Program at InTouch Primary Care

Dr. Adelola Ashaye has launched Metabolic Wellness & Healthy Weight Program at InTouch Primary Care, offering a personalized, medically guided approach to sustainable weight loss...

Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit

MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs) 
MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs)

Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 24 July 2025 - Ipsen announced today that the European Commission has approved Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues.

Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics

Omniscient and The Jacobs Institute launch Connectomics Innovation Program to advance stroke recovery and neurologic care with AI-enabled software.

Knee Replacement Surgery Market worth $16.17 billion in 2030 with 6.1% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The global Knee Replacement Surgery Market, valued at US$10.86 billion in 2023 stood at US$12.00 billion in 2025...

IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma

The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohortsDarovasertib has received U.S. FDA Breakthrough Therapy Designation...

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations 
Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations

Johnson & Johnson showcases latest advancements in Alzheimer’s research at AAIC 2025

Early data from robust Autonomy Phase 2b posdinemab trial demonstrate Company's leadership in multimodal biomarkers and early detection New findings highlight the central role of...

Exhale Expands THCA Collection With Two Best THCA Flower Strains: Godfather OG and Hawaiian Haze

Exhale Wellness, a leading hemp-based wellness brands, introduced two new THCA flower strains in July 2025. Read more about their features. 
Exhale Wellness, a leading hemp-based wellness brands, introduced two new THCA flower strains in July 2025. Read more about their features.

Citryll Announces Formation of Scientific Advisory Board

CITRYLL ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD

Happy Docs Make Happy Patients

AI technology boosts face-to-face time with patients, earns Mercy national recognition for physician satisfaction ST. LOUIS, July 23, 2025 /PRNewswire/ -- Mercy's strategic and carefully planned...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

DEADLINE ALERT for VSTS, RCKT, TEM, and DDD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, July 23, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedicine

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers